Siblia
Phage Display Vaccines: New Possibilities for Antigen Presentation and Vaccine Research
A 2026 study of a lambda phage platform targeting EGFRvIII highlights the potential of multivalent antigen display, while underscoring the challenges of translating experimental vaccine designs into effective immunization strategies. What the 2026 EGFRvIII Study Demonstrated In March 2026, NIH-affiliated scientists reported a lambda (λ) bacteriophage engineered to display an...
118 Προβολές
© 2026 Siblia Σε σύνδεση: 10 Σήμερα: 343 Yesterday: 274 This Week: 568 This Month: 568 This Year: 568 Σύνολο: 568 Visitor Analytics